Suchergebnisse - "Andraca-Carrera, Eugenio"

PubPharm (9)

1

A structured framework for adaptively incorporating external evidence in sequentially monitored clinical trials

enthalten in: Journal of biopharmaceutical statistics | 2022

von Kwiatkowski, E. | Andraca-Carrera, E. | Soukup, M. | +1

2

A structured framework for adaptively incorporating external evidence in sequentially monitored clinical trials

enthalten in: Journal of biopharmaceutical statistics | 2022

von Kwiatkowski, E. | Andraca-Carrera, E. | Soukup, M. | +1

3

Assessing the Safety of Glucose-Lowering Drugs - A New Focus for the FDA

enthalten in: The New England journal of medicine | 2020

von Chong, W. | Yanoff, L. | Andraca-Carrera, E. | +1

4

Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial

enthalten in: The New England journal of medicine | 2020

von Sharretts, J. | Galescu, O. | Gomatam, S. | +3

5

Underscoring the Importance of Allopurinol in Treating Gout : Results of a Food and Drug Administration-Mandated Safety Trial

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2020

von Nikolov, N. | Seymour, S. | Neuner, R. | +3

6

Underscoring the Importance of Allopurinol in Treating Gout : Results of a Food and Drug Administration–Mandated Safety Trial

enthalten in: Arthritis & Rheumatology | 2020

von Nikolov, N. | Seymour, S. | Neuner, R. | +3

7

Inhaled Corticosteroids and LABAs - Removal of the FDA's Boxed Warning

enthalten in: The New England journal of medicine | 2018

von Seymour, S. | Lim, R. | Xia, C. | +2

8

No association of abacavir use with myocardial infarction : findings of an FDA meta-analysis

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2012

von Ding, X. | Andraca-Carrera, E. | Cooper, C. | +4

9

Clinical Science - No Association of Abacavir Use With Myocardial Infarction: Findings of an FDA Meta-Analysis

enthalten in: Journal of acquired immune deficiency syndromes | 2012

von Ding, X. | Andraca-Carrera, E. | Cooper, C. | +4

1
[1]